04/12/2019
An exciting piece of news has been published -- an organization, coincidentally named Frequency Therapeutics" (which has no relation to us), has reported early successes in a trial of a regenerative therapy for hearing loss patients. While additional trials are needed, the therapy could not only prove effective in hearing loss, but also in other degenerative diseases.
“If successful, our lead development program would represent the first time ever that hearing could be restored in humans with a therapeutic,” said Marc Cohen, Frequency’s Executive Chairman. “We are defining a new mode of regenerative medicine: activating progenitor cells within your body to repair damaged tissue.”
“If successful, our lead development program would represent the first time ever that hearing could be restored in humans with a therapeutic"